Discover 3,564 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,564
Positive Affect Treatment for Adolescents With Early Life Adversity
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
for
Open Angle Glaucoma (OAG),
Location: Glendale CA, Charleston SC, New York NY, Boston MA
Sponsor: Life Biosciences Inc.
Sex: All
Age: 40 - 70+
Code: NCT07290244
Phase1, Recruiting
New
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
for
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus,
Location: Los Angeles CA
Sponsor: AstraZeneca
Sex: All
Age: 5 - 70+
Code: NCT07691970
Phase3, Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for
Lupus Nephritis, Primary Membranous Nephropathy
Location: Tustin CA, Ann Arbor MI, Stony Brook NY, Dallas TX,
Sponsor: Nkarta, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06557265
Phase1, Phase2, Recruiting
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
for
Colorectal Cancer Screening
Location: Tustin CA, Lancaster CA, Chula Vista CA, San Antonio TX,
Sponsor: CellMax Life
Sex: All
Age: 45 - 70+
Code: NCT05127096
Recruiting
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
for
Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer
Location: Santa Monica CA, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07070466
Phase2, Recruiting
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
for
Huntington Disease
Location: Irvine CA
Sponsor: Leslie Thompson
Sex: All
Age: 18 - 65
Code: NCT07451613
Phase1, Phase2, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Irvine CA, Tucson AZ, Nampa ID, Meridian ID, Boise ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase2, Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
for
Hepatocellular Carcinoma (HCC)
Location: Duarte CA, Portland OR, Nashville TN, Hackensack NJ
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07291076
Phase1, Phase2, Recruiting
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
for
Hemophagocytic Lymphohistiocytoses
Location: Irvine CA, San Diego CA, San Francisco CA,